+
Diagnosis Before Age 50
The study specifically examined early-onset colorectal cancer, defined as diagnosis before age 50.
Environmental & Mass Tort Division
Colorectal Cancer Lawsuit
New Research Is Raising Serious Questions About Early-Onset Colorectal Cancer
For many people diagnosed with colorectal cancer before age 50, the hardest question isn't treatment, it's understanding why it happened.
They have no significant family history. Genetic testing comes back negative. Traditional risk factors don't fully explain the diagnosis.
Now, emerging research published in Nature Medicine has identified a significant association between epigenetic evidence of Picloram exposure and early-onset colorectal cancer. The findings have attracted attention from scientists, physicians, and legal investigators examining whether environmental exposures may play a role in certain colorectal cancer diagnoses.
If you were diagnosed with colorectal cancer before age 50, PARRIS is reviewing a limited number of cases to determine whether the science may support a potential legal claim.
Request a Free & Confidential Case ReviewNo cost · No obligation · Confidential
+
Since 1985
Established Track Record
+
Billions Recovered
For Our Clients
+
Trial-Ready
Litigation Team
+
Environmental
& Mass Tort Division
The Science
What Is the Picloram Colorectal Cancer Lawsuit?
The potential Picloram lawsuit centers on research published in 2026 by investigators at the Vall d'Hebron Institute of Oncology in Barcelona.
Researchers analyzed tumor tissue, cancer databases, and population-level exposure data to determine whether environmental factors could help explain the growing rise in early-onset colorectal cancer.
Among numerous environmental factors studied, Picloram emerged as the strongest and most statistically significant pesticide association.
The study found:
- Patients with high Picloram-related methylation signatures were significantly more likely to develop early-onset colorectal cancer
- The findings replicated across nine independent cancer cohorts
- Population-level analysis of 94 U.S. counties over 21 years showed a correlation between higher Picloram use and higher early-onset colorectal cancer rates
- Researchers identified distinct biological patterns inside tumors associated with the exposure signature
The study does not automatically establish legal liability. However, it provides scientific evidence that may justify further investigation in qualifying cases.
Case Review
Who May Qualify for a Colorectal Cancer Lawsuit?
Not everyone diagnosed with colorectal cancer will qualify. Our attorneys are focused on evaluating cases that align with the scientific profile described in the research. Potential qualifying factors may include:
+
Limited Family History
Many patients in the study did not have close relatives with colorectal cancer.
+
Negative Genetic Testing
The absence of known hereditary syndromes may increase the relevance of environmental exposure theories.
+
Available Tumor Tissue
Tumor samples preserved during surgery or biopsy may contain information relevant to scientific analysis.
+
Long-Term Exposure Pathways
Exposure extends far beyond direct farm labor. Due to Picloram's widespread, persistent use on California rangelands and pastures, the herbicide systematically migrates into rural groundwater tables and the commercial food supply via contaminated livestock grazing pathways.
Molecular Evidence
Why Tumor Tissue May Matter
One of the most important aspects of the research is that investigators were not simply studying exposure estimates.
They examined molecular evidence inside the tumor tissue itself.
Researchers identified what they described as "epigenetic fingerprints," specific DNA methylation patterns associated with environmental exposures. These fingerprints may remain detectable years after exposure occurs.
Our specialized legal team actively coordinates with hospital pathology departments to formally secure, preserve, and audit these formalin-fixed paraffin-embedded (FFPE) tissue blocks before institutional retention windows expire and critical evidence is routinely destroyed.
A legal review may include determining:
- +Whether tissue is still available
- +Whether records can be obtained
- +Whether further scientific evaluation is appropriate
- +Whether the available evidence supports additional investigation
By the Numbers
What the Research Shows
3.06x
Reported strength of the Picloram methylation association in the study models
9
Independent cancer cohorts where the findings replicated
94
U.S. counties examined in the population-level analysis
21 Years
Span of population data reviewed for exposure and incidence
Figures reflect published study findings and are presented for informational purposes only, not as legal conclusions.
Our Approach
Why PARRIS Is Reviewing These Cases
PARRIS treats complex environmental litigation with elite scrutiny, backed by a 37-year track record and over $1.9 billion recovered for clients. Our Mass Tort Division systematically audits emerging toxicology data, partnering with premier molecular pathologists to establish bulletproof causation models required to defeat corporate defendants in high-stakes courtrooms.
A scientific publication alone does not create a lawsuit.
The question is whether a specific person's diagnosis can be connected to scientifically supported evidence.
That is why we are carefully reviewing a limited number of cases rather than accepting every inquiry.
Answers
Frequently Asked Questions
What is Picloram?+
Picloram is a synthetic herbicide first registered in the United States in 1964. It has been used on rangeland, pasture, grain crops, and rights-of-way.
Can pesticide exposure cause colorectal cancer?+
Researchers recently identified a significant association between Picloram-related epigenetic signatures and early-onset colorectal cancer. Additional scientific and legal investigation is ongoing.
Do I need to have worked with pesticides?+
No. Due to persistent herbicide use on regional pastures, Picloram frequently migrates into California groundwater tables and consumer food supplies via contaminated livestock grazing pathways.
What if my genetic testing was negative?+
Negative genetic testing may increase the relevance of environmental exposure theories because it removes some common hereditary explanations for colorectal cancer.
Can my tumor tissue still be tested?+
Often, yes. Many pathology laboratories retain preserved tissue samples for years following diagnosis and treatment.
Is there a cost for a legal review?+
No. PARRIS provides free and confidential case evaluations.
Client Testimonials
What Our Clients Have To Say About Us
Free & Confidential
Request a Free Case Evaluation
Many people diagnosed with early-onset colorectal cancer are still searching for answers about why it happened.
Emerging scientific evidence may provide part of that answer.
If you were diagnosed with colorectal cancer before age 50 and believe your circumstances may align with the research discussed above, our team can evaluate whether the available science supports further investigation.
Schedule your free and confidential consultation that carries no obligation today.
Request Your Case Review
Free & confidential. There is no cost and no obligation.
Submitting this form does not create an attorney-client relationship. Information shared is kept confidential and used only to evaluate a potential claim.
